160 related articles for article (PubMed ID: 1665293)
1. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
[TBL] [Abstract][Full Text] [Related]
2. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
3. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.
Tries S; Neupert W; Laufer S
Inflamm Res; 2002 Mar; 51(3):135-43. PubMed ID: 12005204
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation.
Hoult JR; Forder RA; de las Heras B; Lobo IB; Payá M
Agents Actions; 1994 Aug; 42(1-2):44-9. PubMed ID: 7847183
[TBL] [Abstract][Full Text] [Related]
6. A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice.
Ishii K; Motoyoshi S; Kawata J; Nakagawa H; Takeyama K
Jpn J Pharmacol; 1994 Aug; 65(4):297-303. PubMed ID: 7990266
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
8. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
10. Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man.
Depré M; Van Hecken A; Verbesselt R; Verpooten GA; Arnout J; Brunner F; Jurgens A; Pousset V; Chow A; Baldauf C; Vermylen J; De Broe M; De Schepper PJ
Int J Clin Pharmacol Res; 1996; 16(1):1-8. PubMed ID: 9001924
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
Griswold DE; Marshall PJ; Lee JC; Webb EF; Hillegass LM; Wartell J; Newton J; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):825-31. PubMed ID: 1907825
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation.
Rao TS; Currie JL; Shaffer AF; Isakson PC
Inflammation; 1993 Dec; 17(6):723-41. PubMed ID: 8112831
[TBL] [Abstract][Full Text] [Related]
14. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
15. Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.
Kreft AF; Failli AA; Musser JH; Kubrak DM; Banker AL; Steffan R; Demerson CA; Nelson JA; Shah US; Gray W
Drugs Exp Clin Res; 1991; 17(8):381-7. PubMed ID: 1822830
[TBL] [Abstract][Full Text] [Related]
16. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
17. Effect of manoalide on human 5-lipoxygenase activity.
Cabré F; Carabaza A; Suesa N; García AM; Rotllan E; Gómez M; Tost D; Mauleón D; Carganico G
Inflamm Res; 1996 May; 45(5):218-23. PubMed ID: 8737743
[TBL] [Abstract][Full Text] [Related]
18. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
20. Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase?
Proudman KE; McMillan RM
Agents Actions; 1991 Sep; 34(1-2):121-4. PubMed ID: 1793015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
